Gaining access to Retatrutide, the new medication for obesity treatment , currently presents a challenge for many. At present, it isn't widely available in most areas . Limited clinical trials and a selective rollout are being responsible to this situation. Patients interested in receiving Retatrutide should discuss their physician to determine sui